TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

ROSEN, A LEADING NATIONAL FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Rosen Law Firm
ROSEN, A LEADING NATIONAL FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

Rosen Law Firm is notifying DexCom investors of a securities class action lawsuit alleging the company made false statements about design changes and reliability of its G6 and G7 continuous glucose monitoring systems without FDA authorization.

Insights
BACpS   negative

Buffett sold 41% of Berkshire's stake due to potential interest rate sensitivity, high valuation premium, and potential future tax considerations


DXCM   negative

The lawsuit alleges the company made misleading statements about product design, reliability, and potential health risks, which could lead to regulatory scrutiny, legal challenges, and reputational damage